Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk?
about
The empirical status of the ultra high-risk (prodromal) research paradigmAntiglucocorticoid and related treatments for psychosisAntiglucocorticoid and related treatments for psychosisEarly intervention in psychosis: concepts, evidence and future directionsThe antecedents of schizophrenia: a review of birth cohort studiesVoxel-wise meta-analysis of fMRI studies in patients at clinical high risk for psychosisSubstance use in clinical high risk for psychosis: a review of the literatureFunctional outcome in people at high risk for psychosis predicted by thalamic glutamate levels and prefronto-striatal activationIn vivo assessment of neurotransmitters and modulators with magnetic resonance spectroscopy: application to schizophreniaTransition to psychosis associated with prefrontal and subcortical dysfunction in ultra high-risk individuals.Early recognition and disease prediction in the at-risk mental states for psychosis using neurocognitive pattern classification.Basic symptoms and ultrahigh risk criteria: symptom development in the initial prodromal state.Prevalence of attenuated psychotic symptoms and their relationship with DSM-IV diagnoses in a general psychiatric outpatient clinic.A single blind randomized controlled trial of cognitive behavioural therapy in a help-seeking population with an At Risk Mental State for psychosis: the Dutch Early Detection and Intervention Evaluation (EDIE-NL) trial.Using clinical information to make individualized prognostic predictions in people at ultra high risk for psychosis.The psychosis risk syndrome and its proposed inclusion in the DSM-V: a risk-benefit analysis.Early signs, diagnosis and therapeutics of the prodromal phase of schizophrenia and related psychotic disordersAdvances in the genetics of schizophrenia: will high-risk copy number variants be useful in clinical genetics or diagnostics?Basic self-disturbance predicts psychosis onset in the ultra high risk for psychosis "prodromal" population.Relationship between brain glutamate levels and clinical outcome in individuals at ultra high risk of psychosis.Neurological soft signs predict abnormal cerebellar-thalamic tract development and negative symptoms in adolescents at high risk for psychosis: a longitudinal perspective.Ultra high risk of psychosis on committal to a young offender prison: an unrecognised opportunity for early intervention.Trauma history characteristics associated with mental states at clinical high risk for psychosis.The reliability and validity of the korean version of the structured interview for prodromal syndrome.Self-Disorders and Clinical High Risk for Psychosis: An Empirical Study in Help-Seeking Youth Attending Community Mental Health FacilitiesTen-year audit of clients presenting to a specialised service for young people experiencing or at increased risk for psychosis.Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North AmericaLooking at the schizophrenia spectrum through the prism of self-disorders: an empirical study.The case for including Attenuated Psychotic Symptoms Syndrome in DSM-5 as a psychosis risk syndrome.Symptom assessment in early psychosis: the use of well-established rating scales in clinical high-risk and recent-onset populations.Whither the attenuated psychosis syndrome?Treatment history in the psychosis prodrome: characteristics of the North American Prodrome Longitudinal Study CohortPrevention of the first episode of psychosis.Different vulnerability indicators for psychosis and their neuropsychological characteristics in the Northern Finland 1986 Birth Cohort.Substance use in people at clinical high-risk for psychosis.Hierarchical cultural values predict success and mortality in high-stakes teams.Recruitment strategies for the detection of individuals at clinical high risk of developing psychosisPrimary prevention of psychosis through interventions in the symptomatic prodromal phase, a pragmatic Norwegian Ultra High Risk study.Cognitive alexithymia is associated with the degree of risk for psychosis.Evidence that psychotic symptoms are prevalent in disorders of anxiety and depression, impacting on illness onset, risk, and severity--implications for diagnosis and ultra-high risk research.
P2860
Q22242833-C4949AAD-4A11-47A0-A00F-A9A3ABD42322Q24186594-F8E7ABFD-F0ED-456E-B0C7-5B24689309ABQ24243495-52902752-85F3-4C46-9992-50CA65154406Q24658167-94E03A75-3471-4FC2-9883-E609CAABB902Q24658348-7AE64BFB-CD12-467C-B1D9-BB6F9C60C9B2Q26829555-FBA46C0F-63DD-469A-A5F3-C4BE60AA758CQ26859349-05E17860-40F8-42D6-9B2D-07A85D27BA71Q27320072-D8EAE4D7-3A82-4DEB-AABA-D64651EB3562Q28083121-E03CBF45-5882-4892-8C06-E1DE6E0262F0Q30447851-EEBF3E59-8AAD-41D0-9CC0-6DD0C00CAAA8Q30447856-63ABFFC0-95D3-40B6-B748-3AC4A69E8374Q30477949-E980A279-1186-442B-A2B7-D34B3EE7407DQ33677429-495B2958-66E0-4B6C-AC41-AC27E990B3CCQ33784930-674A688A-1B1A-491F-8CDB-746931619711Q33814290-6A650ED4-AC99-4288-87CD-88055307295FQ34071212-4FA471C3-8BCD-471A-B1AA-9EF7918B9C7DQ34095720-AD33907F-634E-4FFC-B531-0C229E389A90Q34167342-5E6AA0D0-A20F-4800-8A4B-842D909BFB12Q34255756-DA825C04-336D-4972-9DF3-6EA98B46E983Q34270086-E6682693-A048-477B-B99B-256EBE32A11DQ34322929-9188B96B-0754-426D-8E66-3FE2AE5E127BQ34365907-DACA1A5A-CDD2-4AB1-A05B-1E10F5321F81Q34446370-02FF2E2C-F7CF-45A8-88DF-A7AE0DAF6F7AQ34497547-E7F9A688-CEF9-4531-A50E-D2EFA83377D5Q34508665-23DDDBC9-13FF-4A9B-92FB-4D99485DBD88Q34551433-27597266-62D8-4F0A-AD47-A3D1CA2B158EQ34586836-975E2CFB-3A8D-4057-A197-E2C4C98C714BQ34604263-5D74612C-2059-4967-830B-C72BB956020BQ34623331-04A622A1-C5F3-4A93-909C-0488054508B4Q34644328-A7890470-4ADF-4034-9DB9-363623DDEF40Q34645261-FCDD4736-E255-4052-9A04-8C43BA69AC83Q34727780-E71BC2FE-5240-4CF7-B8B4-2AB0A0B35680Q34776827-67CACBC0-3D98-43D7-9552-3FBC564C388AQ34863670-30DF936A-3636-46AB-B845-081C0BF6559DQ34987780-40861F54-E10B-4EE5-854A-8064F5400766Q35062793-1BB60863-E8ED-4E10-A4CE-AAF527372A50Q35168094-57CD0DF1-41E3-4DB6-A7F9-C8F6DD39042BQ35576996-F15574CB-76E1-4587-B660-2CCB38B48C64Q35647896-33AF2FB0-A23F-4EFD-9AD5-6EADDA173F24Q35768192-2101E97D-B370-4EB9-804E-FE63C29BB9AE
P2860
Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk?
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Declining transition rate in u ...... dilution or reduction of risk?
@ast
Declining transition rate in u ...... dilution or reduction of risk?
@en
type
label
Declining transition rate in u ...... dilution or reduction of risk?
@ast
Declining transition rate in u ...... dilution or reduction of risk?
@en
prefLabel
Declining transition rate in u ...... dilution or reduction of risk?
@ast
Declining transition rate in u ...... dilution or reduction of risk?
@en
P2093
P2860
P50
P356
P1476
Declining transition rate in u ...... dilution or reduction of risk?
@en
P2093
Barnaby Nelson
Gregor Berger
Hok Pan Yuen
Patrick McGorry
Shona Francey
Te-Chieh Hung
P2860
P304
P356
10.1093/SCHBUL/SBM015
P407
P577
2007-04-02T00:00:00Z